BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.090
-0.360 (-10.43%)
At close: Aug 14, 2026, 4:00 PM EDT
3.110
+0.020 (0.65%)
After-hours: Aug 14, 2026, 7:34 PM EDT
BioAtla Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.96 | 7.12 | 49.05 | 111.47 | 215.51 | 244.98 |
Cash & Short-Term Investments | 1.96 | 7.12 | 49.05 | 111.47 | 215.51 | 244.98 |
Cash Growth | -93.94% | -85.49% | -56.00% | -48.27% | -12.03% | 2.67% |
Prepaid Expenses | 0.24 | 0.23 | 0.45 | 0.32 | 0.54 | 0.5 |
Other Current Assets | 0.89 | 0.66 | 1.74 | 4.62 | 4.39 | 1.81 |
Total Current Assets | 3.09 | 8.01 | 51.23 | 116.41 | 220.43 | 247.29 |
Property, Plant & Equipment | 5.31 | 5.65 | 1.19 | 3.1 | 5.15 | 6.98 |
Other Long-Term Assets | 0.16 | 0.16 | - | 0.15 | 0.15 | 0.15 |
Total Assets | 8.57 | 13.83 | 52.42 | 119.66 | 225.74 | 254.42 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.12 | 8.19 | 1.9 | 3.82 | 4.23 | 1.18 |
Accrued Expenses | 7.01 | 8.16 | 11.8 | 22.9 | 17.38 | 17.25 |
Current Portion of Leases | 1.56 | 1.43 | 0.84 | 1.62 | 1.52 | 1.39 |
Other Current Liabilities | - | 4.14 | - | - | - | - |
Total Current Liabilities | 20.69 | 21.92 | 14.54 | 28.34 | 23.13 | 19.81 |
Long-Term Leases | 4.54 | 4.77 | - | 0.84 | 2.46 | 3.98 |
Other Long-Term Liabilities | 20.65 | 23.32 | 23.62 | 19.81 | 19.81 | 19.81 |
Total Liabilities | 45.88 | 50.02 | 38.16 | 48.99 | 45.4 | 43.6 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Additional Paid-In Capital | 514.68 | 509.45 | 500.3 | 486.93 | 473.14 | 397.14 |
Retained Earnings | -551.99 | -545.65 | -486.04 | -416.26 | -292.8 | -186.32 |
Total Common Equity | -37.31 | -36.19 | 14.27 | 70.67 | 180.34 | 210.82 |
Shareholders' Equity | -37.31 | -36.19 | 14.27 | 70.67 | 180.34 | 210.82 |
Total Liabilities & Equity | 8.57 | 13.83 | 52.42 | 119.66 | 225.74 | 254.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.09 | 6.2 | 0.84 | 2.46 | 3.98 | 5.37 |
Net Cash (Debt) | -4.13 | 0.92 | 48.21 | 109.01 | 211.53 | 239.61 |
Net Cash Growth | - | -98.10% | -55.77% | -48.46% | -11.72% | 0.71% |
Net Cash Per Share | -3.28 | 0.78 | 49.63 | 114.08 | 271.69 | 346.64 |
Filing Date Shares Outstanding | 1.66 | 1.66 | 1.17 | 0.96 | 0.95 | 2.21 |
Total Common Shares Outstanding | 1.66 | 1.27 | 1.16 | 0.96 | 2.14 | 2.21 |
Working Capital | -17.6 | -13.91 | 36.69 | 88.06 | 197.3 | 227.48 |
Book Value Per Share | -22.48 | -28.51 | 12.28 | 73.50 | 84.32 | 95.48 |
Tangible Book Value | -37.31 | -36.19 | 14.27 | 70.67 | 180.34 | 210.82 |
Tangible Book Value Per Share | -22.48 | -28.51 | 12.28 | 73.50 | 84.32 | 95.48 |
Machinery | 2.93 | 2.93 | 4 | 4 | 4.41 | 4.25 |
Leasehold Improvements | 2.5 | 2.5 | 3.68 | 3.68 | 3.69 | 3.69 |